1. |
Rao S, Elkon B, Flett KB, et al. Long-term outcomes and risk factors associated with acute encephalitis in children. Journal of the Pediatric Infectious Diseases Society, 2017, 6(1): 20-27.
|
2. |
Fowler A, Stodberg T, Eriksson M, et al. Long-term outcomes of acute encephalitis in childhood. Pediatrics, 2010, 126(4): e828-e835.
|
3. |
Lee W, Yu T, Chang W, et al. Risk factors for postencephalitic epilepsy in children: A hospital-based study in Taiwan. European Journal of Paediatric Neurology, 2007, 11(5): 302-309.
|
4. |
Chen YJ, Fang PC, Chow JC. Clinical characteristics and prognostic factors of postencephalitic epilepsy in children. J Child Neurol, 2006, 21(12): 1047-1051.
|
5. |
Pillai SC, Mohammad SS, Hacohen Y, et al. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors. Epilepsia, 2016, 57(1): e7-e11.
|
6. |
Singh TD, Fugate JE, Hocker SE, et al. Postencephalitic epilepsy: Clinical characteristics and predictors. Epilepsia, 2015, 56(1): 133-138.
|
7. |
Pedersen E. Postencephalitic Epilepsy. Epilepsia, 1964, (5): 43-50.
|
8. |
Yoshioka M, Kuroki S, Mizue H. Clinical and electroencephalographic studies of postencephalitic epilepsy. Acta Paediatr Jpn, 1989, 31(4): 480-483.
|
9. |
Lin K, Lin J, Hsia S, et al. Effect of antiepileptic drugs for acute and chronic seizures in children with encephalitis. PLOS ONE, 2015, 10(10): e139974.
|
10. |
Robert SF, Carlos A, Alexis A, et al. A practical clinical definition of epilepsy. Epilepsia, 2014, 55(4): 475-482.
|
11. |
Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology, 1988, 38(9): 1407-1410.
|
12. |
Spatola M, Dalmau J. Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Current Opinion in Neurology, 2017, 30(3): 345-353.
|
13. |
Jorina ME, Ari B, Susan E, et al. A 12-Year prospective study of childhood herpes simplex encephalitis: Is there a broader spectrum of disease? Pediatrics, 2007, 119(2): e399-e407.
|
14. |
Lin J, Hsia S, Wu C, et al. Mycoplasma pneumoniae-related postencephalitic epilepsy in children. Epilepsia, 2011, 52(11): 1979-1985.
|
15. |
Liu X, Yan B, Wang R, et al. Seizure outcomes in patients with anti‐NMDAR encephalitis: A follow‐up study. Epilepsia, 2017, 58(12): 2104-2111.
|
16. |
李静, 张振国, 孙印旗, 等. 细菌性脑炎/脑膜炎 266 例流行病学分析. 预防医学情报杂志, 2012, 28(05): 334-336.
|
17. |
Yao L, Yue W, Xunyi W, et al. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China. Journal of Clinical Neuroscience, 2019, 68: 73-79.
|
18. |
Bartolini L, Theodore WH, Jacobson S, et al. Infection with HHV-6 and its role in epilepsy. Epilepsy Research, 2019, 153: 34-39.
|
19. |
Vezzani A, Lang B, Aronica E. Immunity and inflammation in epilepsy. Cold Spring Harbor Perspectives in Medicine, 2016, 6(2): a22699.
|
20. |
van Vliet E A, Aronica E, Vezzani A, et al. Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathology and Applied Neurobiology, 2018, 44(1): 91-111.
|
21. |
Vezzani A, Fujinami RS, White HS, et al. Infections, inflammation and epilepsy. Acta Neuropathologica, 2016, 131(2): 211-234.
|
22. |
张伊佳, 秦炯. 免疫炎症因素在癫痫中的作用机制. 中国免疫学杂志, 2019, 35(8): 1024-1026.
|
23. |
Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol, 2019, 15(8): 459-472.
|
24. |
Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia, 2008, 49(1): 13-18.
|
25. |
Sellner J, Trinka E. Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management. Journal of Neurology, 2012, 259(10): 2019-2030.
|
26. |
Vogrig A. Postencephalitic epilepsy in children andadults: Etiology matters. Epilepsia, 2016, 57(4): 671-672.
|
27. |
Singh TD, Rabinstein AA. In response: Postencephalitic epilepsy inchildren and adults: Etiology matters. Epilepsia, 2016, 57(4): 672-673.
|
28. |
Pillai S, Dale RC. In response: Postencephalitic epilepsy in children and adults: Etiology matters. Epilepsia, 2016, 57(4): 677-678.
|
29. |
Misra UK, Kalita J. Seizures in encephalitis: Predictors and outcome. Seizure, 2009, 18(8): 583-587.
|
30. |
Hosoya M, Ushiku H, Arakawa H, et al. Low-voltage activity in EEG during acute phase of encephalitis predicts unfavorable neurological outcome. Brain & Development, 2002, 24(3): 161-165.
|
31. |
Rismanchi N, Gold JJ, Sattar S, et al. Epilepsy after resolution of presumed childhood encephalitis. Pediatric Neurology, 2015, 53(1): 65-72.
|
32. |
Ko T, Holmes GL. EEG and clinical predictors of medically intractable childhood epilepsy. Clinical Neurophysiology, 1999, 110(7): 1245-1251.
|
33. |
Ellul M, Solomon T. Acute encephalitis-diagnosis and management. Clin Med (Lond), 2018, 18(2): 155-159.
|
34. |
Gunawardane N, Fields M. Acute symptomatic seizures and provoked seizures: to treat or not to treat? Current Treatment Options in Neurology, 2018, 20(10).
|
35. |
Michael BD, Solomon T. Seizures and encephalitis: Clinical features, management, and potential pathophysiologic mechanisms. Epilepsia, 2012, 53(1): 63-71.
|
36. |
Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure, 2014, 23(3): 167-174.
|
37. |
Ramantani G, Holthausen H. Epilepsy after cerebral infection: review of the literature and the potential for surgery. Epileptic Disorders, 2017, 19(2): 117-136.
|
38. |
赵萌, 关宇光, 周健, 等. 迷走神经刺激术治疗儿童脑炎后药物难治性癫痫的疗效分析. 中华实用儿科临床杂志, 2018, 33(23): 1820-1822.
|
39. |
Pitkänen A. Therapeutic approaches to epileptogenesis-Hope on the horizon. Epilepsia, 2010, 51(1): 2-17.
|
40. |
Leng X, Yuan F, Zhao J, et al. Long-term seizure outcome in patients with status epilepticus due to acute encephalitis. Seizure, 2019, 69: 70-75.
|